(Q48683722)

14 February 2018

title

Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. (English)

1 reference

14 February 2018

0 references

O Sabri

1

1 reference

14 February 2018

R Erkwoh

2

1 reference

14 February 2018

M Schreckenberger

3

1 reference

14 February 2018

A Owega

4

1 reference

14 February 2018

H Sass

5

1 reference

14 February 2018

U Buell

6

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

14 February 2018

published in

The Lancet

1 reference

14 February 2018

volume

349

1 reference

14 February 2018

page(s)

1735-1739

1 reference

14 February 2018

issue

9067

1 reference

14 February 2018

Patterns of metabolic activity in the treatment of schizophrenia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

A controlled study of 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

What does rCBF-SPECT offer in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

Negative symptoms and hypofrontality in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

Patterns of cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

A factor analytic study of symptoms in acute schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2908380-8

7 January 2021

10.1016/S0140-6736(96)08380-8

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9193384

1 reference

14 February 2018